Home|Journals|Articles by Year

Directory for Medical Articles
 

Case Report

J App Pharm Sci. 2017; 7(1): 214-216


Penfluridol Induced Extrapyramidal symptoms (EPS): A Case Report

Sereen Rose Thomson, Balaji Ommurugan, Shalini Adiga, Navin Patil, Saurish Reddy.


Abstract

Penfluridol is a long acting oral antipsychotic agent taken once a week for the treatment of schizophrenia and other psychotic disorders. Weekly dosage regimen of the drug makes it an ideal drug in non-compliant patients, which is commonly seen in 50-75% of psychotic disorder patients. Better compliance may be associated with less relapses, better quality of life, less crises and less or shorter hospitalizations, leading to lower costs.
As a part of pharmacovigilance program of India, we hereby report a case of Penfluridol induced extrapyramidal symptoms in a patient with refractory schizophrenia who developed EPS even at the least possible dose of the drug. Relevant data was collected from case record as per Central Drug Standard Control Organisation form and causality, severity and preventability assessment was done as per Naranjo’s, Hartwigs and Schumock and Thornton scales respectively.

Key words: Typical antipsychotics, extrapyramidal symptoms, adverse drug reaction, refractory schizophrenia.






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net







Do you want to use OJS for your journal ?
work with an experienced partner
www.OJSHosting.net

eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.